Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Commentary

Research Type: Commentary

Sort 1 results by:

Filter Applied. Clear All

Latest Posts

September 16, 2026 Examining women’s experiences with medication abortion: a critical inquiry of women’s online narratives post-Dobbs Examining women’s experiences with medication abortion: a critical inquiry of women’s online narratives post-Dobbs September 15, 2026 New Study: Abortion, Natural Pregnancy Loss Are Risk Factors for Future Maternal Complications New Study: Abortion, Natural Pregnancy Loss Are Risk Factors for Future Maternal Complications September 15, 2026 Fact Sheet: Fetal Development Education in the United States Fact Sheet: Fetal Development Education in the United States
Reset All Filters
Maternal & Public Health

Online Mail-Order Chemical Abortion: A Threat to Abuse and Trafficking Victims

As the summer of 2023 proceeds, a federal appeals court is continuing its deliberation over a lawsuit against the Food and Drug Administration (FDA) over the conditions for distribution of the abortion pill mifepristone.  At issue are an array of FDA decisions to ease access to the drug, including allowing its distribution by mail and with little to no medical oversight.

Life & the Law

The Life-Saving Impact of State Actions Following the Dobbs Decision: A Case Study of Plummeting 2022 Abortion Totals in Oklahoma and Arkansas

In a world obsessed with “following the science,” it is surprising that some in the government and American culture do not “follow the science” when it comes to the reality that life begins at conception.

Maternal & Public Health

Pro-Life States Are Putting Their Money Where Their Mouths Are

Media outlets on the Left constantly berate pro-lifers and accuse them of forgetting about children after they’re born. They push false narratives that the pro-life movement wants to deprive women of opportunities and prevent children from obtaining a safe and fair upbringing.

Life & the Law

From the Desk of CLI’s President: A Reflection One Year Post-Dobbs

As we mark the first anniversary of the Supreme Court decision in Dobbs v. Jackson Women’s Health Organization, one thing is clear: The debate the Supreme Court’s 5-4 majority invited by reversing Roe v. Wade is happening - and it is intense.

Life & the Law

The Democrats’ Misguided Demand for Taxpayer-Funded Abortion

Over the long decades of debate about legal abortion in the United States, there are only a few constants. One of them has been that the Congress will not compel the American people to finance abortions for the poor, federal employees, members of the military, beneficiaries of the Indian Health Service, and other public insurance programs.

Five Things We Don’t Know about Abortion in the U.S. (but Could with Better Reporting)
Life & the Law

Five Things We Don’t Know about Abortion in the U.S. (but Could with Better Reporting)

Here are five things that everyone should know about abortion in the United States – but cannot because of the poor state of abortion reporting.

End of Life

Washington State: Expanding Death Without Dignity

On February 27, the Washington state senate decided to subject many more of its residents to the risk of being hastened toward death by drug overdose.

Life & the Law

Lozier Institute Amicus Brief in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration

The U.S. Food & Drug Administration (FDA) claims that “[b]enefit-risk assessment is the foundation for” the agency’s “regulatory review of human drugs and biologics.” But when it comes to abortion regulation, particularly chemical abortion regulation, that foundation is severely compromised.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image